Form 8-K - Current report:
SEC Accession No. 0001193125-24-247653
Filing Date
2024-10-30
Accepted
2024-10-30 17:05:59
Documents
14
Period of Report
2024-10-30
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d871314d8k.htm   iXBRL 8-K 27190
2 EX-99.1 d871314dex991.htm EX-99.1 4706
  Complete submission text file 0001193125-24-247653.txt   153400

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA me-20241030.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE me-20241030_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE me-20241030_pre.xml EX-101.PRE 10811
17 EXTRACTED XBRL INSTANCE DOCUMENT d871314d8k_htm.xml XML 3547
Mailing Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086
Business Address 223 N. MATHILDA AVE. SUNNYVALE CA 94086 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

EIN.: 871240344 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-39587 | Film No.: 241411320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)